A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

COVID-19 accelerates the progression of atherosclerotic plaques, increasing coronary inflammation and the risk of high-risk ...

As Elon Musk moves to shutter the U.S. Agency for International Development, the agency’s support for the discovery of novel ...

Teaming up to raise awareness of the continuing toll of COVID-19 in America, an ongoing mass disabling event causing an American death ...

Reports of the human metapneumovirus (HMPV) have caused concern as cases rise in China and the UK, evoking fears reminiscent ...

The source of the SARS-CoV-2 virus, which causes COVID-19, remains elusive. With "low confidence, "some federal agencies ...

China has not declared a "state of emergency" over the human metapneumovirus (HMPV) after infections increased toward the end ...

Uganda started an Ebola Sudan virus vaccination trial on Monday, four days after an outbreak was confirmed, the WHO announced, beginning with those deemed at highest risk of the disease.

The flu can also cause a general feeling of fatigue or malaise, Ray says, as well as gastrointestinal issues like diarrhea and nausea, especially among children. As with COVID-19, some people also ...

Health experts are seeing signs of a much smaller wave of U.S. COVID-19 cases this winter than in previous years, which could ...

PEMGARDA™ (pemivibart) net product revenue of $13.8 million, 48% growth over Q3 2024 net product revenue of $9.3 ...

The Central Intelligence Agency (CIA) now believes that the COVID-19 virus originated from a lab in China, The New York ...